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SUMMARY
Objective: To determine the prevalence of active convulsive epilepsy (ACE) and describe
the clinical characteristics and associated factors among a rural Ugandan population.
Methods: The entire population in Iganga/Mayuge Health Demographic Surveillance
Site (IM-HDSS) was screened using two questions about seizures during a door-
to-door census exercise. Those who screened positive were assessed by a clinician to
confirm diagnosis of epilepsy. A case control study with the patients diagnosed with
ACE as the cases and age/sex-matched controls in a ratio of 1:1 was conducted.
Results: A total of 64,172 (92.8%) IM-HDSS residents, with a median age of 15.0 years
(interquartile range [IQR]: 8.0–29.0), were screened for epilepsy. There were 152 con-
firmed ACE cases, with a prevalence of 10.3/1,000 (95% confidence interval [CI]: 9.5–
11.1) adjusted for nonresponse and screening sensitivity. Prevalence declined with age,
with the highest prevalence in the 0–5 years age group. In an analysis of n = 241 that
included cases not identified in the survey, nearly 70% were unaware of their diagnosis.
Seizures were mostly of focal onset in 193 (80%), with poor electroencephalogram
(EEG) agreement with seizure semiology. Antiepileptic drug use was rare, noted in
21.2% (95% CI: 16.5–25.8), and 119 (49.3%) reported using traditional medicines. His-
tory of an abnormal antenatal period (adjusted odds ratio [aOR] 10.28; 95%CI 1.26–
83.45; p = 0.029) and difficulties in feeding, crying, breathing in the perinatal period
(aOR 10.07; 95%CI 1.24–81.97; p = 0.031) were associated with ACE in children. In
adults a family history of epilepsy (aOR 4.38 95%CI 1.77–10.81; p = 0.001) was the only
factor associated with ACE.
Significance: There is a considerable burden of epilepsy, low awareness, and a large
treatment gap in this population of rural sub-Saharan Africa. The identification of
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adverse perinatal events as a risk factor for developing epilepsy in children suggests
that epilepsy burdenmay be decreased by improving obstetric and postnatal care.
KEY WORDS: Adverse perinatal events, Population study of epilepsy, Risk factors,
Treatment gap, Uganda.
Epilepsy ranks as one of the most common chronic neuro-
logical disorders with significant personal and social
impact. Approximately 70 million people are living with
epilepsy worldwide1 with the majority (>80%) living in
low- and middle-income countries (LMICs).2 The sub-
Saharan Africa (SSA) region alone is estimated to have at
least 10 million persons with epilepsy (PWEs).3
There is a paucity of epidemiologic studies designed
to determine the prevalence of epilepsy in Uganda and
factors associated with the disease. Furthermore, the rel-
atively efficient and inexpensive hospital and medical
records–based approaches frequently used in the devel-
oped world to determine prevalence are not widely avail-
able nor well developed in most SSA countries; this
approach may be difficult to implement given poor
health services utilization by PWEs in LMICs. A recent
cross-sectional community-based study conducted in
rural Uganda in an area of endemic seasonal malaria
specifically examined only disabled children for whom
epilepsy was the sole or major complaint.4 However, this
community study by Duggan relied only on those cases
with long-standing recurrent seizures who were able to
come for assessment at the government health centers or
church halls, and individuals >18 years were excluded.4
The prevalence of epilepsy from Duggan’s study and the
description of the seizure patterns are not comprehensive
because the case identification methods used are subject
to selection bias.
Earlier studies of epilepsy in Uganda have largely been
small, hospital-based, and descriptive in nature,5,6 with
none examining the most widely recognized risk factors.
Therefore, findings from such studies are not representative
because most PWEs rarely access health care facilities for
treatment. There are many reasons for the poor uptake of
medical services, including poor understanding of the cause
of epilepsy; health systems with few skilled staff and limited
investigative facilities; lack of drugs; and inability to afford
the cost of chronic treatment.3,7
Here we present results of an epidemiological study that
was part of a large multisite study conducted across five
health demographic surveillance systems (HDSSs) in Africa
(http://www.indepth-network.org). The overall aim of this
study was to determine the prevalence, risk factors, and out-
come of epilepsy in five sites across SSA, namely: Ghana,
South Africa, Tanzania, Kenya, and Uganda.8
This paper provides detailed descriptive analysis of the
demographic and clinical characteristics of people with
active convulsive epilepsy (ACE) identified during the pop-
ulation-based survey conducted in Iganga/Mayuge (IM)
HDSS site in Uganda. We specifically set out to determine
the prevalence of epilepsy and to describe the clinical char-
acteristics and the risk factors in these individuals.
Methods
Study area and population
The IM-HDSS is located in the eastern region of Uganda
in the districts of Iganga and Mayuge near the shores of
Lake Victoria. It is a defined area approximately 120 km
from the country’s capital, Kampala. The HDSS area is pre-
dominantly rural but partly periurban around the town of
Iganga with some trading areas and spans a total area of
about 155 km2. At the time of the study, the total population
was approximately 69,186 people.
The population is homogeneous, with about 80% from a
single ethnic group, the Basoga, whose main livelihood is
subsistence agriculture. Most of the population under
surveillance is relatively young, with approximately 50%
aged 15 years and younger.
Study procedure
The study was conducted over an 8-month period from
February to October 2009 using a previously described
three-stage survey methodology9 to identify the epilepsy
cases, as described in the following steps.
Key Points
• Prevalence of epilepsy in Uganda is high and declines
with age, with the highest burden seen in children
younger than the age of 5 years
• Most seizures are of the focal onset type, with discor-
dance between the seizure semiology and EEG fea-
tures
• There is low awareness, a large treatment gap, and
considerable stigma regarding epilepsy in this popula-
tion
• Perinatal infections, neonatal insults, and family his-
tory are important risk factors associated in the devel-
opment of epilepsy
• Efforts to improve the antenatal and postnatal care
may reduce the overall burden of epilepsy
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Stage I: Conducting the screening
During the routine census, the Iganga/Mayuge census
team conducted door-to-door screening of households by
interviewing a senior member of the household (usually
fathers or mothers) using two questions about seizures or
convulsions. The appropriate terminology in the local lan-
guage for the key words in the screening questions (i.e., sei-
zures/convulsions) was derived from prior qualitative
interviews with elders, community health workers, and
caregivers in the community and was pretested in communi-
ties outside the study area. One question asked whether any-
one had fits or had ever been told that they had experienced
convulsions/seizures. The second asked about any experi-
ence of episodes in which their legs or arms had jerking
movements or they had a history of loss of consciousness.
Trained census field workers were Ugandans fluent in Eng-
lish and in local languages spoken in the IM-HDSS area.
Conducting the two-step clinical assessments
Step one (stage II): Screening of the community with an
epilepsy questionnaire
A team of 10 trained Epilepsy Field Workers (EFWs)
then interviewed people who screened positive to any one
of the two questions used during stage I of the study to
establish whether an epilepsy diagnosis was likely. A 10-
item Epilepsy Questionnaire (EQ) with higher specificity
for detecting ACE than the screening questions was used for
this purpose. The questionnaire was based on information
used in international studies10–12 and previous work done in
Kilifi HDSS.13 It was translated into the local vernacular
(Lusoga) by a team of certified professional translators from
the Department of Languages at Makerere University.
Step two (stage III): Neurological confirmation at the
hospital
All those identified by the EQ as potential ACE patients
by the EFWwere invited to Iganga Referral Hospital to con-
firm the diagnosis of ACE and to distinguish subtypes of
epilepsy by a clinician. A diagnosis of epilepsy was made
when there was a history of recurrent (two or more) seizures
unprovoked by any immediate identifiable cause.14 Active
convulsive epilepsy was defined as at least two unprovoked
convulsions (seizures with clonic movements) within the
last year.
Additional eligible cases that had previously not been
identified during the three-stage method were included in
the clinical examination study. These cases were identified
following referral by clinic staff, community leaders, and
following a population screening sample used to assess the
sensitivity of the three-stage methodology.
During the clinical examination, in-depth sociodemo-
graphic, medical, and birth history was obtained using pre-
tested questionnaires (different questionnaires were used
for individuals younger and older than 18 years). All
neurological examination findings were recorded on a stan-
dardized form developed for this study following which a
blood sample was taken. A trained nurse performed an elec-
troencephalogram (EEG) in those with ACE to classify the
types of seizures and epilepsy syndrome according to old
and new International League Against Epilepsy (ILAE) cri-
teria15,16 and to detect any evidence of focal lesions. EEG
was performed using a 16-channel digital recording system
(Grass Technologies, Warwick, RI, U.S.A.), with electrode
placement according to the international 10–20 system. All
EEGs were interpreted by Eddie Chengo using a protocol
founded on standard methods for EEG reporting and in line
with the conventional definitions of the principal EEG fea-
tures commonly assessed in clinical practice. The seizure
classification was independently assessed by two neurolo-
gists (CRJCN and AKM) to minimize bias.
To compare the three-stage survey method of this study
with the traditional two-stage methods used in other studies
in LMICs, a sample of 5,000 residents of the IM-HDSS
study area was randomly selected from the census database
and interviewed by fieldworkers using the EQ. At the end of
the assessments, those patients who required further clinical
assessment (potential ACE) were given appointments and
facilitated to attend Iganga Referral Hospital.
The case control study
We conducted a case control study with patients diag-
nosed with ACE during stage III of the prevalence survey as
the cases. These were matched to selected population con-
trols using the age bands 0–5, 6–12, 13–18, 19–28, 29–49,
and 50 years and older on a ratio of 1:1, randomly chosen
from the census database. All controls were invited to the
referral hospital for stage III assessment by interviewers and
clinicians who were blind to their case-control status. If any
subject recruited as a control was subsequently found to
have ACE that subject was reclassified as a case and a suit-
able replacement was selected from the database.
Serological testing
Serological tests were conducted on blood samples from
cases and controls to determine exposure to neurocysticer-
cosis using a Western blotting technique,17 onchocerciasis
using a modified ELISA test,18 toxocariasis using an ELISA
IgG and IgG4 Toxocara commercial kit (Cypress Diagnos-
tics, Belgium), toxoplasmosis using the Toxoplasma IgG
Elisa kit (Abbott Toxo IgG ELISA, Genesis Diagnostics),
and HIV using the ABOTTDETERMINE test (Abbott Park,
IL, U.S.A.).19
Investigated risk factors
Data on sociodemographic variables, past medical his-
tory (history of diabetes mellitus, maternal seizures, or
hypertension in the family), family history of seizures,
nonclinical associated factors (perinatal events,
previous head injuries, diet), and social history (alcohol/
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recreational drug consumption) were collected by field-
workers while the clinical history was obtained by clini-
cians. For the study participants younger than 18 years,
the mother or guardian was interviewed and additional
questions on antenatal and perinatal events and the pres-
ence of pets in the home were included. Adverse perina-
tal events were defined as difficulties in breathing,
crying, or feeding after birth as recalled by the mother.
A positive family history of epilepsy was defined as a
history of anyone in the family (first- or second-degree
relatives) who had seizures (fits). In assessing malnutri-
tion, anthropometric measurements were taken, including
body weight, height/length, and presence of edema for
children younger than age 5 years. World Health Organi-
zation (WHO) Child Growth Standards in monitoring
growth and motor development were utilized using the
WHO Anthro software20 to compute standardized z
scores of weight for height in children up to age 5 years,
where ≤2 standard deviation (SD) scores indicated mal-
nutrition. For those older than 5 years, body mass index
(BMI) was calculated according to the equation: BMI =
Weight (Kg)/Height2 (m), with a cut-off of BMI <16 for
females and <15 for males indicating malnutrition using
WHO standards.
Statistical analysis
Data were double entered into a mySQL database
version 5 open source database (Oracle Corporation,
Redwood Shores, CA, U.S.A.) and cleaned by examin-
ing outliers and missing values and by comparing the
two entries. The data were then transferred into STATA
11 (StataCorp, College Station, TX, U.S.A.) for statisti-
cal analysis. The estimated unadjusted prevalence of
ACE and 95% confidence interval (CI) was calculated
as the number of cases of ACE confirmed in stage III
divided by the total population screened in stage I,
expressed per 1,000 persons. Multiple imputation21 was
used to reduce bias in the prevalence estimates due to
attrition between stages of the survey. In addition, the
prevalence estimates were adjusted for the sensitivity of
the three-stage method.22 Logistic regression was used
to estimate the odds ratio for the association between
each potentially predictive factor and ACE adjusted for
confounding resulting from age, sex, and maternal edu-
cation.
Ethical approval
Ethical clearance to conduct this study was granted by
the School of Public Health Research and Ethics Com-
mittee, Makerere University College of Health Sciences,
and Uganda National Council for Science and Technol-
ogy (Ref: HS 663), and by the Committee for the Protec-
tion of Human Subjects, University College of London.
Written informed consent was sought from each partici-
pant in the study.
Results
Sociodemographics of the study population screened in
Iganga HDSS
From the eligible population of 69,186 persons in Iganga,
a total of 64,172 (92.8%) persons were screened for convul-
sions in the DSS in stage I. The median age of the total pop-
ulation screened in the prevalence part of the study was
15.0 years (interquartile range [IQR]: 8.0–29.0) with simi-
lar numbers of females and males (Table 1).
Prevalence of epilepsy
The study procedure and the detailed results of the three-
stage screening survey are provided in Fig. 1.
There were 152 cases with confirmed ACE, giving a
crude prevalence rate of 2.4/1,000 (95% CI: 2.1–2.8). The
prevalence in males was not significantly higher than in
females. After adjusting for attrition and sensitivity of the
three-stage methodology, the epilepsy prevalence was 10.3/
1,000 (95% CI: 9.5–11.1).
The median age of these cases was 11.0 (6.0–19.0) years,
the median age at onset of their ACE was 2.1 (0.8–6.6)
years, and the median duration of their epilepsy was 6.0
(3.0–12.0) years.
Age-specific epilepsy prevalence
Prevalence varied with age, being highest in the
0–5 years age band and declining with age, as is shown in
Fig. 2. The epilepsy prevalence adjusted for age and stan-
dardized to the mid-2000 U.S. population was 6.8 (6.2–7.5)
per 1,000 persons.
Clinical characteristics of the seizures
For this part of the analysis, we used n = 241 cases,
which included eligible cases obtained from the population
Table 1. History, frequency, and occurrence of the
seizures
Characteristic/history (n = 241) Years/N (%)
Median age at onset of the seizures (IQR), in years 6.0 (3.0–13.0)
Family history of seizures 35 (14.5)
Parents with history of seizures 8 (3.3)
Siblings with history of seizures 40 (16.6)
Family history of febrile seizures 48 (19.9)
Seizure frequency (n = 241)
Daily 33 (13.7)
Weekly 36 (14.9)
Monthly 65 (27.0)
Yearly 101 (42.0)
Uncertain 6 (2.4)
Time of seizure occurrence (n = 241)
Daytime 41 (17.0)
Nighttime 14 (5.8)
Both day and night time 177 (73.4)
Uncertain 9 (3.7)
IQR, interquartile range.
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screening sample used to assess the sensitivity of the three-
stage methodology and referrals by the clinic staff and com-
munity leaders. Approximately one-third, or 72 (29.8%)
subjects, had ever been told they had fits. There were no dif-
ferences in sex ratio (males = 121 [50.2%]), and the median
age was 10.0 years (IQR: 5.0–19.0).
History pertaining to the seizures
The median age at onset of seizures was 6.0 years (IQR:
3.0–13.0). One in 5 cases had a family history of febrile sei-
zures. Other medical history variables are shown in Table 1.
Seizure frequency
Seizures occurred daily in only 14% and yearly in 42%
(Table 1).
Seizure semiology
The most common seizure types were of focal onset
(80%), with more than half (55%) being of the motor
onset-clonic type (impaired awareness), as is shown in
Table 2.
Electroencephalographic features
The EEG recordings were available for 234 persons with
ACE, and of these more than half (129, or 55.1%) were nor-
mal, while 102 (43.6%) were abnormal and 3 (1.3%) unde-
termined. Epileptic activity such as spikes, sharp waves,
spike+wave, and rhythmic runs was present in 67/234
(28.6%) of the EEG readings. There was discordance in the
seizure semiology and EEG features recorded, with the most
frequent abnormal epileptiform activity observed in order
of frequency as focal extratemporal 51 (50.0%), focal tem-
poral 48 (47.0%), multifocal 28 (27.5%), and generalized
abnormalities 16 (15.7%).
Antiepileptic drug use
There was minimal and irregular supply of antiepileptic
drugs (AEDs) at the referral hospital during the time of this
Figure 1.
Flow diagram showing selection of study participants and prevalence of active convulsive epilepsy in Iganga-Mayuge HDSS. ACE- active
convulsive epilepsy. #On the basis of estimates adjusted for attrition and sensitivity; p = 0.006.
Epilepsia Open ILAE
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study and none available at the lower-level health units. Of
the 241 persons with epilepsy, only 51 (21.2%, 95% CI:
16.5–25.8) reported use of AEDs, whereas nearly half (119,
or 49.3%) reported using traditional medicines. The epi-
lepsy treatment gap was 78.8%.
Risk factors for epilepsy
Risk factors for epilepsy in children and adults are shown
in Tables 3 and 4. Children with a history of an abnormal
antenatal period or difficulties in feeding, crying, or breath-
ing in the perinatal period were 10 times more likely to have
epilepsy (adjusted odds ratio [aOR] 10.28; 95% CI: 1.26–
83.45) and (aOR 10.07; 95% CI: 1.24–81.97), respectively.
In addition, a positive history of seizures in the family (aOR
2.64; 95% CI: 1.21–5.77; p = 0.015) and exposure toOnch-
ocerca volvulus (aOR 4.03; 95% CI: 1.16–14.00;
p = 0.028) were also associated with epilepsy in the chil-
dren. Other risk factors are shown in Table 3.
In contrast, in adults (Table 4), the only factor associated
with epilepsy was a positive history of seizures in the family
(aOR 4.38 95% CI: 1.77–10.81; p = 0.001).
Discussion
This study investigated the prevalence, clinical char-
acteristics, and associated factors for epilepsy in a rural
Ugandan population. The estimated overall epilepsy
prevalence was 10.3 per 1,000. The prevalence declined
with age. In children, history of complications in the
antenatal period and adverse perinatal events were iden-
tified as important risk factors, and a family history of
seizures was the factor most strongly associated with
epilepsy in adults. Focal onset seizures were the most
common seizure type. Awareness of epilepsy among
cases was low, and many preferred to use traditional
medicines rather than AEDs.
Figure 2.
Age-specific prevalence of active convulsive epilepsy in Iganga-Mayuge HDSS.
Epilepsia Open ILAE
Table 2. Seizure type classifications among n = 241 epilepsy patients
Seizure typea Generalized onset No. (%) Focal onset No. (%) Unknown onset No. (%)
Motor—all with
impaired
awareness
Focal (clonic) to bilateral
tonic-clonic seizure with
impaired awareness
55 (22.8) Unclassified—impaired
awareness
31 (12.9)
Tonic-clonic 7 (2.9)
Myoclonic 2 (0.8) Motor onset oral-facial
automatisms
1 (0.4)
Absences 7 (2.9) Non–motor onset
cognitive—impaired
awareness
3 (1.2)
Motor-epileptic
spasms
1 (0.4) Non–motor onset
sensory—impaired
awareness
2 (0.8)
Motor onset-clonic—impaired
awareness
132 (54.8)
Total 17 (7.04) 193 (80.07) 31 (12.86)
aUsing revised ILAE classifications, 2017, seizure types not exclusive.
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Prevalence of epilepsy
We found a high prevalence of epilepsy in this rural com-
munity; however, this figure may not be comparable to the
12.7/1,000 cases of active epilepsy reported in a meta-ana-
lysis of studies in rural low-resource settings1 or the 13.5/
1,000 (95% CI 10.2–17.2) in rural areas of Latin American
Table 3. Risk factors for epilepsy among children (aged < 18 years) in Iganga/MayugeHDSS
Children with no ACE Children with ACE
Unadjusted
Adjusted (age, sex, maternal
education)
% (n/N) % (n/N) OR (95% CI) p value OR (95% CI) p value
Seizures in the family 9.4 (16/171) 24.2 (38/157) 3.09 (1.64,5.81) <0.001 2.64 (1.21,5.77) 0.015
Maternal seizures 1.2 (2/171) 2.6 (4/155) 2.24 (0.40,12.39) 0.356 1.13 (0.14,8.49) 0.907
Abnormal delivery 1.8 (3/166) 3.2 (5/157) 1.79 (0.42, 7.61) 0.432 0.95 (0.19,4.90) 0.957
Abnormal antenatal period 1.2 (2/167) 8.9 (14/156) 8.13 (1.82,36.39) 0.006 10.28 (1.26,83.45) 0.029
Home delivery 14.1 (24/170) 28.7 (45/157) 2.78 (1.53,5.04) 0.001 3.02 (1.38,6.60) 0.006
Problems after birth 2.4 (4/169) 6.4 (10/156) 2.82 (0.87,9.20) 0.085 3.18 (0.62,16.36) 0.166
Difficulties feeding, crying, or breathing 1.8 (3/166) 5.9 (9/152) 3.42 (0.91,12.88) 0.069 10.07 (1.24,81.97) 0.031
Head injury 0.6 (1/170) 3.9 (6/155) 6.85 (0.81,57.56) 0.076 6.76 (0.79,57.70) 0.081
Malnourished 42.9 (55/128) 38.9 (44/113) 0.85 (0.50,1.42) 0.526 0.86 (0.46,1.63) 0.647
Eats cassava 89.5 (154/172) 94.3 (148/157) 1.92 (0.84,4.41) 0.123 2.03 (0.78,5.29) 0.145
Dogs in household 15.7 (27/172) 6.4 (10/157) 0.36 (0.17,0.78) 0.009 0.44 (0.17,1.14) 0.091
Cats in household 4.1 (7/172) 1.3 (2/157) 0.30 (0.06,1.49) 0.141 0.32 (0.03,3.13) 0.327
Eats pork 10.5 (18/171) 12.8 (20/156) 1.26 (0.64,2.48) 0.505 1.59 (0.68,3.76) 0.285
Malaria IgG + ve (schizont) 99.2 (129/130) 100 (87/87) 1 NA NA NA
Hospitalized with malaria or fever 5.8 (10/172) 4.5 (7/157) 0.76 (0.28,2.04) 0.580 0.94 (0.32,2.72) 0.903
Toxocara canis IgG4 + ve 18.5 (24/130) 19.5 (17/87) 1.07 (0.53,2.14) 0.842 1.00 (0.39,2.58) 0.998
Toxoplasma gondii IgG + ve 20.0 (26/130) 22.9 (20/87) 1.19 (0.62,2.31) 0.598 1.37 (0.57,3.26) 0.479
Taenia solium + ve 1.5 (2/130) 0.0 (0/87) NA NA NA NA
Onchocerca volvulus + ve 4.6 (6/130) 12.6 (11/87) 2.99 (1.06,8.42) 0.038 4.03 (1.16,14.00) 0.028
HIV + ve 2.3 (3/130) 3.4 (3/87) 1.51 (0.29,7.66) 0.618 1.66 (0.22,12.46) 0.623
ACE, active convulsive epilepsy; CI, confidence interval; IgG, immunoglobulin G; OR, odds ratio.
Table 4. Risk factors for epilepsy among adults (aged ≥ 18 years) in Iganga/MayugeHDSS
Adults with no ACE Adults with ACE
Unadjusted
Adjusted (age, sex, maternal
education)
% (n/N) % (n/N) OR (95% CI) p value OR (95%CI) p value
Seizures in the family 10.8 (9/83) 33.3 (19/57) 4.11 (1.69,9.95) 0.002 4.38 (1.77,10.81) 0.001
Maternal seizures 0.0 (0/84) 1.7 (1/57) 1 NA NA NA
Abnormal delivery 2.4 (2/83) 1.8 (1/56) 0.74 (0.06,8.32) 0.80 0.79 (0.07,9.17) 0.852
Home delivery 43.3 (42/97) 35.9 (23/64) 0.71 (0.36,1.41) 0.332 0.59 (0.28,1.23) 0.160
Problems after birth 0.0 (0/79) 7.8 (4/51) 1 NA NA NA
Head injury 1.2 (1/81) 8.8 (5/57) 7.84 (0.89,69.07) 0.064 8.12 (0.90, 73.19) 0.06
Drinks alcohol 11.4 (8/70) 16.0 (8/50) 1.48 (0.50,4.14) 0.469 1.29 (0.40,4.13) 0.666
Eats cassava 92.8 (77/83) 100.0 (57/57) 1 NA NA
Eats pork 12.9 (9/70) 21.1 (11/52) 1.82 (0.69,4.78) 0.225 1.79 (0.66,4.84) 0.248
Uses drugs 25.3 (21/83) 20.7 (12/58) 0.77 (0.34,1.72) 0.525 0.79 (0.35,1.81) 0.591
Hypertension 1.2 (1/83) 1.7 (1/58) 1.44 (0.09,23.48) 0.799 1.99 (0.10,39.49) 0.650
Stroke 0.0 (0/83) 1.7 (1/58) 1 NA NA NA
Diabetes mellitus 0.0 (0/83) 0.0 (0/58) NA NA NA NA
Malnourished 16.7 (14/84) 24.6 (14/57) 1.63 (0.71,3.74) 0.251 1.54 (0.65,3.60) 0.321
Dogs in household 13.4 (11/82) 10.3 (6/58) 0.74 (0.26,2.14) 0.585 0.75 (0.26,2.19) 0.606
Cats in household 2.4 (2/82) 1.7 (1/58) 0.70 (0.06,7.93) 0.775 0.92 (0.08,10.66) 0.948
Malaria IgG + ve (schizont) 100.0 (73/73) 100.0 (38/38) NA NA NA NA
Hospitalized with malaria/fever 4.0 (4/100) 7.7 (5/65) 2.00 (0.52,7.74) 0.316 2.28 (0.57,9.14) 0.244
Toxocara canis IgG4 + ve 35.6 (26/73) 44.7 (17/38) 1.46 (0.66,3.25) 0.350 1.37 (0.60,3.10) 0.450
Toxoplasma gondii IgG + ve 39.7 (29/73) 36.8 (14/38) 0.88 (0.39,1.99) 0.767 0.86 (0.38,1.97) 0.728
Taenia solium + ve 0.0 (0/73) 0.0 (0/38) NA NA NA NA
Onchocerca volvulus + ve 8.2 (6/73) 5.3 (2/38) 0.62 (0.11,3.23) 0.571 0.63 (0.12,3.44) 0.599
HIV + ve 2.7 (2/73) 5.3 (2/38) 1.97 (0.27,14.58) 0.506 1.25 (0.15,10.44) 0.834
ACE, active convulsive epilepsy; CI, confidence interval; IgG, immunoglobulin G; OR, odds ratio.
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countries,23 given that we were screening for ACE, which
represents up to 25–50% of all epilepsies in a population-
based study.9,24 It is therefore likely that the epilepsy preva-
lence we measured in this population is much higher.
The unadjusted prevalence of ACE was lower than that of
the other demographic sites in SSA yet similar to that from
the Ghanaian HDSS site.1 Conversely, following adjust-
ment for the screening tool and attrition in the three-stage
survey, our prevalence was the second highest after that of
the Tanzanian HDSS site.
The heterogeneity in prevalence in the different HDSS
sites could be ascribed to varied environmental or associ-
ated genetic factors in each of these settings. Notably, in
IM-HDSS, once the community realized that clinical care
was being provided for the ACE cases, several patients who
had previously been “hidden” surfaced and presented as
cases to the clinic. This situation was responsible for the rise
in the number of ACE cases seen in the subsequent clinical
studies. Such a situation highlights the issue of social stigma
surrounding epilepsy25 and the low community awareness
regarding this condition.26
In the age-specific prevalence, we observed that preva-
lence was highest in the age group <5 years and steadily
declined with age. This could likely be due to the reported
high rate of birth injury, infection, and head trauma during
early childhood noted in poor regions of the world27 and
high premature mortality and spontaneous remission rates.
This is supported by our data, which showed that history of
perinatal complications was a key associated factor for the
children with epilepsy. We also observed a high percentage
of cases with a family history of acute convulsions that
could have been contributory, as has been confirmed in a
recent study.28 The decline of prevalence with age could be
a result of decreased survival and has been noted in other
rural communities.9 There have been high mortality rates
reported in patients with epilepsy from rural communities in
Africa29,30 often as a result of status epilepticus, sudden
unexpected death, nonaccidental burn injuries during the
epileptic attacks, and drowning. Alternatively, it could be
due to spontaneous remission of the epilepsy as the patients
grew older. This latter hypothesis requires further study of
the natural history of epilepsy in this population.
Clinical characteristics of the seizures
The most common seizure type was focal onset sei-
zures, comprising more than three-quarters of the sei-
zures in this group of PWEs. There was low awareness
regarding epilepsy among the patients, with two-thirds
being unaware they had a diagnosis of epilepsy. The
low awareness regarding epilepsy in the rural communi-
ties of many LMICs has previously been reported.31,32
This information underlines the need to support pro-
grams geared at creating awareness among patients with
epilepsy and addressing misconceptions attached to epi-
lepsy. The lack of awareness often makes PWEs delay
health seeking and also perpetuates stigmatization, dis-
crimination, and exclusion from society.
Focal onset seizures were common in our population, but
more than half of the EEG recordings were normal. In the
literature, a normal EEG does not exclude epilepsy because
around 10% of patients with epilepsy never show interictal
epileptiform discharges (IEDs). About 50% of patients with
epilepsy, however, will show IEDs in their first EEG test.33
A number of factors may have influenced our EEG findings.
The circadian variation may have played a part, especially
as has been reported in idiopathic generalized epilepsies.
Second, the seizure frequency in our population was low,
with more patients reporting seizures yearly rather than
daily. Patients with frequent (one per month) seizures have
been noted to be more likely to have IEDs than those with
rare (one per year) attacks.34 Third, the timing of the EEG
recording may have been contributory: investigations done
within 24 h of a seizure have been shown to reveal IEDs in
51% compared with 34% in those who had a later EEG.35
Whereas equipment maintenance in LMIC settings is a rec-
ognized challenge, we believe that this issue was unlikely to
have had an impact on our EEG findings because precau-
tions were taken to ensure that the EGG equipment was well
calibrated, stored under lock and key, and managed by only
one trained nurse.
The discordance in the seizure semiology and EEG fea-
tures seen in our study may indicate localized structural
pathology underlying the seizure disorders in our population
or diffuse cortical dysfunction as is seen in symptomatic
generalized epilepsies.33 This explanation may further sup-
port the hypothesis of a high rate of infection and traumas
during early childhood as a common phenomenon in this
population.
Treatment in epilepsy
This study noted an epilepsy treatment gap of close to
80%, in keeping with the ranges reported for LMICs.36,37
The treatment gap is a crucial global challenge of epilepsy
care in LMICs. The large treatment gap could have been
compounded by the low awareness of epilepsy, the afford-
ability and availability of care and treatment, or likely social
stigma surrounding the disease. Furthermore, health system
issues such as absence of primary health workers trained to
diagnose and treat epilepsy coupled with limited access to
the health facilities, especially in rural areas, may have been
contributory. It would be important to ascertain the actual
causes of not seeking modern health care in this rural com-
munity by conducting further studies.
The use of traditional therapy for epilepsy was popular in
this community, with nearly a half reporting the use of tradi-
tional medicines. Traditional medicine usage is common in
SSA and likely stems from the traditional animistic religious
beliefs,38 which impel PWEs to seek this treatment in prefer-
ence to biomedical treatment as a result of their perceptions
and superstitions about the origins and causes of disease. The
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use of traditional medicines requires further study to analyze
its benefits as well as to consider the possibility of incorpo-
rating the traditional healer as an important stakeholder in
the management of this complex health condition.
Risk factors for epilepsy
In general, a history of complications during the perinatal
period was associated with epilepsy in this population. Sim-
ilar findings have been noted in rural studies done within the
region.39,40 This finding is potentially of public health
importance because it points toward the need for ensuring a
successful, closely monitored pregnancy period for Ugan-
dan mothers and rigorous emergency and obstetric care for
the mother-baby pair. Preventive measures directed at
improvement in these areas may play a role in reducing the
risk of epilepsy in the child population.
We noted that epilepsy was associated with onchocercia-
sis antibody positivity in those younger than 18 years.
Whereas the reason for this association still remains
unknown, this finding is in agreement with several other
studies that have indicated high prevalence of epilepsy in
onchocerciasis endemic areas, especially in northern
Uganda where the “nodding syndrome” (NS) has been
described41,42 and in other regions of Africa.43
Adults were more likely to have epilepsy if they had a
positive family history of seizures. The strong association of
family history of seizures with epilepsy for both children
and adults has consistently been noted in previous studies
done in Africa9,39,40 as well as in other population stud-
ies,44,45 which noted a two- to fourfold increased risk of epi-
lepsy among the first-degree relatives of people with
genetic epilepsies or epilepsies whose cause was unknown,
compared with the general population.
This finding suggests that genetic factors may play a sig-
nificant role in the etiology of epilepsy in our population, or
these results may denote a higher awareness of seizures and
epilepsy in persons who had a positive family history of epi-
lepsy.
Limitations and strengths
Notably in our study we only detected convulsive epilep-
sies and heavily relied on the history from the main care-
giver and adult patients. For children, it is possible that
mothers may be more likely to remember and report a child
as having had difficulty, say, with breathing or feeding if
such a child was subsequently identified as having a convul-
sive disease. These narratives may have been prone to recall
and response biases, and the clinical classification method
that we used may have underestimated the presence of focal
onset seizures that rapidly generalize to bilateral tonic clo-
nic. Furthermore, the high nonresponse rate we initially
obtained in the first stage of the survey, which we attributed
to social stigma, may have affected the actual number of
patients identified, though we adjusted for the sensitivity of
the screening methodology. The prevalence of febrile
seizures in this population was high, and though we used
evidence of fever witnessed by the caregiver as a distin-
guishing feature between febrile and nonfebrile seizures,
this classification may not be very precise because determi-
nation of the presence of fever in some cases was subjective.
The demarcation of actual epileptic seizures from psy-
chogenic nonepileptic seizures (PNESs) and syncope may
be difficult by history taking only.
All our EEG recordings were done once, during the day
time and for the relatively short duration of a routine EEG.
This methodology may have decreased the yield since some
patients show discharges mainly in sleep. Higher yields
have been reported with repeated as well as prolonged inter-
ictal recording EEG recordings.33
Despite our study’s methodological limitations, this by
far is the largest and most comprehensive community sur-
vey of epilepsy in Uganda. Our study findings enhance the
knowledge regarding epilepsy epidemiology in Uganda,
and the study has several potential strengths. The study site
provided an ideal platform to generate population-based
data to inform national health policies and evaluate innova-
tions in assessing the burden of epilepsy in Uganda. Two
neurologists independently reviewed each patient’s clinical
characteristics, and EEG records were interpreted using
standard criteria based on the ILAE guidelines.
Conclusions and
Recommendations
There is a significant burden of epilepsy in this rural
area of Uganda mostly in children younger than 5 years.
The social stigma, irregular AEDs supply, and low com-
munity awareness regarding epilepsy may compromise
the disease’s clinical management and delay treatment
seeking, thus contributing to the large treatment gap we
observed. Perinatal infections, neonatal insults, and
genetic factors are important risk factors for epilepsy.
These findings suggest that improvement in emergency
obstetric and postnatal care may play a role in the preven-
tion of epilepsy in this community. However, endeavors
aimed at further understanding the complex interplay of
these factors in the etiology of epilepsy are warranted. In
addition, the Ugandan Ministry of Health and concerned
stakeholders need to utilize a multipronged approach to
raise awareness regarding epilepsy identification and man-
agement through education of the individual and commu-
nity. Means should be devised to strengthen health
systems, specifically in rural areas, through training of
primary health care workers to manage PWEs and incor-
porate these services into existing local primary health
care programs. Also, the availability of AEDs should be
increased at all levels of health care. Research to deter-
mine the nature and relevant features of the treatment gap
and stigma in epilepsy so as to improve the disease’s
treatment and control are also recommended.
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